The impact of liposomal linolenic acid on gastrointestinal microbiota in mice

BACKGROUND: The prevalence of Helicobacter pylori has long been a global health issue. Triple therapy, being the first-line treatment, has caused dysbiosis of the gastrointestinal tract that led to various complications. A novel nanomedicine – liposomal linolenic acid (LipoLLA) – has been proven to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuan-xuan, Shi, Si, Rong, Lan, Feng, Mei-qing, Zhong, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849918/
https://www.ncbi.nlm.nih.gov/pubmed/29563795
http://dx.doi.org/10.2147/IJN.S151825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849918/
https://www.ncbi.nlm.nih.gov/pubmed/29563795
http://dx.doi.org/10.2147/IJN.S151825

Ejemplares similares